We are international
Donate
TEXT SIZE   


Dr. Cavo - Bortezomib-Based Induction Treatments Improve Outcomes of Newly Diagnosed Multiple Myeloma Patients with High-Risk Cytogenetic Abnormalities
Michele Cavo, MD
Bologna University School of Medicine
Bologna Italy
01.10.11


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles